Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 5/20 | 0.76 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.76 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.59 |
| ▸ | ACHE | P22303 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | DRD3 | P35462 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | PTGES | O14684 | 2/20 | 0.54 |
| ▸ | TOP2A | P11388 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.50 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27816563 | 0.89 | PTPN1 (0.60) | PTPN1PTPN11PTPN2CYP3A4ACHE | |
| SCHEMBL2559667 | 0.86 | PTPN1 (1.00) | PTPN1PTPN11PTPN2CYP3A4ACHE | |
| SCHEMBL29424249 | 0.86 | PTPN1 (1.00) | PTPN1PTPN11PTPN2CYP3A4ACHE | |
| SCHEMBL18677517 | 0.83 | PTPN1 (0.81) | PTPN1PTPN11PTPN2CYP3A4ACHE | |
| SCHEMBL30261073 | 0.83 | PTPN1 (0.81) | PTPN1PTPN11PTPN2CYP3A4ACHE | |
| SCHEMBL15782810 | 0.83 | MEN1 (0.70) | PTPN1PTPN11PTPN2CYP3A4ACHE | |
| SCHEMBL28253661 | 0.82 | PTPN1 (0.64) | PTPN1PTPN11PTPN2CYP3A4ACHE | |
| SCHEMBL9909323 | 0.82 | PTPN1 (0.78) | PTPN1PTPN11PTPN2PTGESTOP2A | |
| SCHEMBL29367141 | 0.82 | PTPN1 (0.78) | PTPN1PTPN11PTPN2PTGESTOP2A | |
| SCHEMBL21383336 | 0.82 | PTPN1 (0.82) | PTPN1PTPN11PTPN2CYP3A4ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230029027-A1 | COMPOSITIONS AND METHODS FOR USING GENETICALLY MODIFIED ENZYMES | RENEW BIOPHARMA, INC. | 2023-01-26 | — | — | US | claimed |
| WO-2020210810-A9 | COMPOSITIONS AND METHODS FOR USING GENETICALLY MODIFIED ENZYMES | RENEW BIOPHARMA, INC. (US) | 2020-11-26 | — | — | WO | claimed |
| WO-2020210810-A1 | COMPOSITIONS AND METHODS FOR USING GENETICALLY MODIFIED ENZYMES | RENEW BIOPHARMA, INC. (US) | 2020-10-15 | — | — | WO | claimed |
| WO-2019183152-A1 | COMPOSITIONS AND METHODS FOR USING GENETICALLY MODIFIED ENZYMES | RENEW BIOPHARMA, INC. (US) | 2019-09-26 | — | — | WO | claimed |
| US-12540315-B2 | Compositions and methods for using genetically modified enzymes | RENEW BIOPHARMA, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| US-20250188050-A1 | RECOMBINANT POLYPEPTIDES WITH BERBERINE BRIDGE ENZYME ACTIVITY USEFUL FOR THE BIOSYNTHESIS OF CANNABINOIDS | INVIZYNE TECHNOLOGIES, INC. (US) | 2025-06-12 | — | — | US | disclosed |
| US-20250043319-A1 | BIOSYNTHESIS OF CYCLOLAVANDULYL DERIVATIVES OF AROMATIC COMPOUNDS | INVIZYNE TECHNOLOGIES, INC. (US) | 2025-02-06 | — | — | US | disclosed |
| US-12084689-B2 | Prenyltransferase variants with increased thermostability | INVIZYNE TECHNOLOGIES, INC. (US) | 2024-09-10 | — | — | US | disclosed |
| WO-2023205404-A2 | BIOSYNTHESIS OF CYCLOLAVANDULYL DERIVATIVES OF AROMATIC COMPOUNDS | INVIZYNE TECHNOLOGIES, INC. (US) | 2023-10-26 | — | — | WO | disclosed |
| WO-2023133483-A1 | RECOMBINANT POLYPEPTIDES WITH BERBERINE BRIDGE ENZYME ACTIVITY USEFUL FOR THE BIOSYNTHESIS OF CANNABINOIDS | INVIZYNE TECHNOLOGIES, INC. (US) | 2023-07-13 | — | — | WO | disclosed |
| US-20230098978-A1 | PRENYLTRANSFERASE VARIANTS WITH INCREASED THERMOSTABILITY | INVIZYNE TECHNOLOGIES, INC. (US) | 2023-03-30 | — | — | US | disclosed |
| US-20230029027-A1 | COMPOSITIONS AND METHODS FOR USING GENETICALLY MODIFIED ENZYMES | RENEW BIOPHARMA, INC. | 2023-01-26 | — | — | US | disclosed |
| WO-2017051020-A1 | DYE COMPOSITION COMPRISING A RESORCINOL-BASED COUPLER AND AN OXIDATION BASE | L'OREAL (FR) | 2017-03-30 | — | — | WO | disclosed |
| CN-102115757-B | Platform hooks biological synthesis gene cluster and the application thereof of mycin | SOUTH CHINA SEA INSTITUTE OF OCEANOLOGY, CHINESE ACADEMY OF SCIENCES (CN) | 2015-10-28 | — | — | CN | disclosed |
| US-9079989-B2 | Charge control resin and manufacturing method of the same | ORIENT CHEMICAL INDUSTRIES CO., LTD. (JP) | 2015-07-14 | — | — | US | disclosed |
| US-20150025213-A1 | CHARGE CONTROL RESIN AND MANUFACTURING METHOD OF THE SAME | ORIENT CHEMICAL INDUSTRIES CO., LTD. (JP) | 2015-01-22 | — | — | US | disclosed |
| US-8883946-B2 | Charge control resin and manufacturing method of the same | ORIENT CHEMICAL INDUSTRIES CO., LTD. (JP) | 2014-11-11 | — | — | US | disclosed |
| US-20140080989-A1 | CHARGE CONTROL RESIN AND MANUFACTURING METHOD OF THE SAME | ORIENT CHEMICAL INDUSTRIES CO., LTD. (JP) | 2014-03-20 | — | — | US | disclosed |
| CN-101817745-B | Chemical synthesis method of 3,5-dichloro-4-hydroxy-2-methoxy-6-methyl-benzoic acid | UNIV HUAZHONG AGRICULTURAL | 2013-03-13 | — | — | CN | disclosed |
| CN-101817745-A | Chemical synthesis method of 3,5-dichloro-4-hydroxy-2-methoxy-6-methyl-benzoic acid | UNIV HUAZHONG AGRICULTURAL | 2010-09-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540315-B2 | Compositions and methods for using genetically modified enzymes | COASY, CYP4F3, CYP4F11 | PTPN1 2972/4885PTPN11 3207/4885PTPN2 3676/4885 |
| US-20250188050-A1 | RECOMBINANT POLYPEPTIDES WITH BERBERINE BRIDGE ENZYME ACTIVITY USEFUL FOR THE BIOSYNTHESIS OF CANNABINOIDS | COASY, CBR1, CBR3 | PTPN1 4410/4885PTPN11 4428/4885PTPN2 4318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.